<IPO>METiS Pharmaceuticals Considering Listing in HK, Raising US$200M: Rumor
METiS Pharmaceuticals, a Chinese company focused on the development of AI medication delivery system...
METiS Pharmaceuticals, a Chinese company focused on the development of AI medication delivery system, is considering a Hong Kong IPO to raise up to US$200 million, Bloomberg quoted sources as saying.
It has been reported that METiS Pharmaceuticals is working with consultants on the IPO, which is likely to take place before the end of this year, with the exact scale and timing subject to change.
Disclaimer: The views in this article are from the original Creator and do not represent the views or position of Hawk Insight. The content of the article is for reference, communication and learning only, and does not constitute investment advice. If it involves copyright issues, please contact us for deletion.